Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Guardian Pharmacy Services, Inc. Class A Common Stock (NY:GRDN)

21.45 -0.68 (-3.07%)
Official Closing Price Updated: 4:10 PM EDT, May 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Guardian Pharmacy Services, Inc. Class A Common Stock

Guardian Pharmacy Services Announces Pricing of Underwritten Public Offering of Class A Common Stock
From Guardian Pharmacy Services, Inc.
Via Business Wire
S&P 500 Moves Lower; Lowe's Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock
From Guardian Pharmacy Services, Inc.
Via Business Wire
Earnings Scheduled For May 12, 2025
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Guardian Pharmacy Services Expands Midwest Long-Term Care Footprint with Wichita, Kansas Pharmacy Acquisition
From Guardian Pharmacy Services, Inc.
Via Business Wire
Guardian Pharmacy Services, Inc. Reports First Quarter 2025 Financial Results
From Guardian Pharmacy Services, Inc.
Via Business Wire
Guardian Pharmacy Services, Inc. Names Ashley Ragsdale Stockton as Head of Investor Relations
From Guardian Pharmacy Services, Inc.
Via Business Wire
Guardian Pharmacy Services, Inc. to Report First Quarter 2025 Financial Results and Host Conference Call
From Guardian Pharmacy Services, Inc.
Via Business Wire
Guardian Pharmacy Services Opens New Columbus, Ohio, Location, Strengthening Long-Term Care Presence in Ohio, Kentucky and West Virginia
From Guardian Pharmacy Services, Inc.
Via Business Wire
Guardian Pharmacy Services Adds Naples Pharmacy to Further Strengthen Long-Term Care Services in Southwest Florida
From Guardian Pharmacy Services, Inc.
Via Business Wire
Guardian Pharmacy Services, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
From Guardian Pharmacy Services, Inc.
Via Business Wire
Earnings Scheduled For March 26, 2025
Via Benzinga
Guardian Pharmacy Services, Inc. Announces Preliminary Fourth Quarter and Full Year 2024 Results; Provides 2025 Financial Guidance and Earnings Conference Call Date
From Guardian Pharmacy Services, Inc.
Via Business Wire
Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference
From Guardian Pharmacy Services, Inc.
Via Business Wire
Guardian Pharmacy Services Expands to New Jersey Through Partnership with Freedom Pharmacy
From Guardian Pharmacy Services, Inc.
Via Business Wire
Zscaler, TransMedics Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Stellantis, PG&E And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Aecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Guardian Pharmacy Services, Inc. Reports Third Quarter 2024 Financial Results
From Guardian Pharmacy Services, Inc.
Via Business Wire
Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference
From Guardian Pharmacy Services, Inc.
Via Business Wire
Guardian Pharmacy Services, Inc. to Report Third Quarter 2024 Financial Results and Host Conference Call
From Guardian Pharmacy Services, Inc.
Via Business Wire
Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Rating
Truist initiates coverage of Guardian Pharmacy, projecting a $22 price target due to strong growth in the $24.8 billion institutional pharmacy market. 
Via Benzinga
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Self-Driving Startup Pony.ai Files For U.S. IPO
Self-driving startup Pony.ai of China filed for an IPO in the U.S. this week. Meanwhile, four companies -- Springview Holdings, Oriental Rise Holdings, PTL Limited, and Samfine Creation Holdings Group... 
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
Obesity Drug Developer BioAge Makes Nasdaq Debut
Shares of BioAge Labs opened for trading this week, with the company planning to use the proceeds of its initial public offering to take its lead obesity drug further into clinical trials. 
Via Talk Markets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.